Theratechnologies Stock In The News

THTX Stock  USD 1.20  0.01  0.83%   
Our overall analysis of Theratechnologies' news coverage and content from conventional and social sources shows investors' bearish mood towards Theratechnologies. The specific impact of Theratechnologies news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Theratechnologies' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Theratechnologies headlines in addition to utilizing other, more conventional financial analysis modules. Check out Theratechnologies Backtesting and Theratechnologies Hype Analysis.
For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.

Theratechnologies Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Theratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation Award
https://www.globenewswire.com/news-release/2023/11/24/2785562/0/en/Theratechnologies-Receives-2023-CQDM-ADRIQ-RSRI-Innovation-Award.html
 Neutral
Macroaxis News: globenewswire.com
Theratechnologies Announces Closing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement
https://www.globenewswire.com/news-release/2023/10/31/2770520/0/en/Theratechnologies-Announces-Closing-of-US-25-Million-Public-Offering-of-Common-Shares-and-Concurrent-Private-Placement.html
 Bullish
Macroaxis News: globenewswire.com
Theratechnologies Announces Pricing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement
https://www.globenewswire.com/news-release/2023/10/26/2767446/0/en/Theratechnologies-Announces-Pricing-of-US-25-Million-Public-Offering-of-Common-Shares-and-Concurrent-Private-Placement.html
 Bullish
Macroaxis News: globenewswire.com
Theratechnologies Announces Proposed Public Offering of Common Shares and Concurrent Private Placement
https://www.globenewswire.com/news-release/2023/10/25/2766949/0/en/Theratechnologies-Announces-Proposed-Public-Offering-of-Common-Shares-and-Concurrent-Private-Placement.html
 Neutral
Macroaxis News: globenewswire.com
Theratechnologies Announces Operational Update
https://www.globenewswire.com/news-release/2023/10/24/2765463/0/en/Theratechnologies-Announces-Operational-Update.html
 Bullish
Macroaxis News: globenewswire.com
Theratechnologies’ Ibalizumab Demonstrat...
https://www.globenewswire.com/news-release/2023/10/19/2763067/0/en/Theratechnologies-Ibalizumab-Demonstrates-Cost-Effectiveness-as-an-Addition-to-Routine-Clinical-Care-in-Heavily-Treatment-Experienced-People-with-HIV.html
 Neutral
Macroaxis News: globenewswire.com
Theratechnologies Announces Finalization of Amendments to Some of the Terms and Conditions of its Credit Agreement with Marathon
https://www.globenewswire.com/news-release/2023/10/16/2760536/0/en/Theratechnologies-Announces-Finalization-of-Amendments-to-Some-of-the-Terms-and-Conditions-of-its-Credit-Agreement-with-Marathon.html
 Neutral
Macroaxis News: globenewswire.com
Theratechnologies Presents Data at ID We...
https://www.globenewswire.com/news-release/2023/10/13/2759892/0/en/Theratechnologies-Presents-Data-at-ID-Week-Showing-Tesamorelin-Reduces-Visceral-Adipose-Tissue-VAT-and-Liver-Fat-in-People-with-HIV-on-Integrase-Inhibitors-INSTIs.html
 Neutral
Macroaxis News: globenewswire.com
Theratechnologies Announces Results from Trogarzo® (Ibalizumab-uiyk) Intramuscular Administration Study
https://www.globenewswire.com/news-release/2023/10/13/2759873/0/en/Theratechnologies-Announces-Results-from-Trogarzo-Ibalizumab-uiyk-Intramuscular-Administration-Study.html
 Neutral
Macroaxis News: globenewswire.com
Theratechnologies Announces Dosing of First Patient in Updated Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
https://www.globenewswire.com/news-release/2023/10/12/2759133/0/en/Theratechnologies-Announces-Dosing-of-First-Patient-in-Updated-Clinical-Trial-of-Sudocetaxel-Zendusortide-in-Advanced-Ovarian-Cancer.html
 Neutral

Theratechnologies Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Theratechnologies and other traded companies coverage with news coverage. We help investors stay connected with Theratechnologies headlines for the 25th of November to make an informed investment decision based on correlating the impacts of news items on Theratechnologies Stock performance. Please note that trading solely based on the Theratechnologies hype is not for everyone as timely availability and quick action are needed to avoid losses.
Theratechnologies' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Theratechnologies investors visualize upcoming and past events in order to time the market based on Theratechnologies noise-free hype analysis.
Theratechnologies stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Theratechnologies earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Theratechnologies that are available to investors today. That information is available publicly through Theratechnologies media outlets and privately through word of mouth or via Theratechnologies internal channels. However, regardless of the origin, that massive amount of Theratechnologies data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Theratechnologies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Theratechnologies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Theratechnologies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Theratechnologies alpha.

Theratechnologies Largest EPS Surprises

Earnings surprises can significantly impact Theratechnologies' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-07-12
2023-05-31-0.1-0.11-0.0110 
2023-02-28
2022-11-30-0.08-0.09-0.0112 
2019-10-08
2019-08-31-0.01-0.02-0.01100 
2018-02-07
2017-11-30-0.02-0.03-0.0150 
2017-10-05
2017-08-31-0.02-0.03-0.0150 
2016-10-04
2016-08-310.020.01-0.0150 
View All Earnings Estimates

Theratechnologies Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Theratechnologies Stock. Current markets are strongly bullish. About 89% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
14th of November 2024
Theratechnologies Share Price Passes Above Fifty Day Moving Average - Time to Sell - Marke...
at news.google.com 
Macroaxis News: globenewswire.com
17th of October 2024
Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of...
at globenewswire.com 
news
11th of October 2024
Theratechnologies Issues Earnings Results
at thelincolnianonline.com 
Macroaxis News
10th of October 2024
Will Theratechnologies turn things around in November
at Macroaxis 
Gurufocus Stories at Macroaxis
9th of October 2024
Earnings to Watch Theratechnologies Inc Reports Q3 2024 Result
at gurufocus.com 
Macroaxis News: globenewswire.com
26th of September 2024
Theratechnologies annoncera ses rsultats financiers du troisime trimestre de lexercice fin...
at globenewswire.com 
Macroaxis News: globenewswire.com
17th of September 2024
Theratechnologies annonce un risque dinterruption temporaire de lapprovisionnement dEGRIFT...
at globenewswire.com 
news
13th of September 2024
Theratechnologies Inc. Sees Significant Increase in Short Interest
at thelincolnianonline.com 
Google News at Macroaxis
3rd of September 2024
Theratechnologies Stock Price Crosses Below 50 Day Moving Average of 1.92 - MarketBeat
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Theratechnologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Theratechnologies' short interest history, or implied volatility extrapolated from Theratechnologies options trading.

Additional Tools for Theratechnologies Stock Analysis

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.